Related Experiment Video
Updated: May 4, 2026
10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.3K
WITHDRAWN: MS related employment and disease modifying treatment in the German working population: 1994-2009
A Korchounov1, T Tabatadze1, D Spivak2
1Clinic of Neurology, Marienhospital Kevelaer, Kevelaer, Germany.
Neurorehabilitation
|January 10, 2014
Abstract:
Ahead of Print article withdrawn by publisher.
Keywords:
Multiple sclerosisdisease modifying treatmentemploymentglatiramerimmunomodulationinterferonretirementMore Related Videos
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
01:29Therapeutic Drug Monitoring: Affecting Factors
429
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
429